Teva Recalls Propofol Injectable Emulsion

Propofol injectable emulsion recalled by Teva.

Teva Pharmaceuticals USA, a generic pharmaceutical company, issued a voluntary recall of Propofol Injectable Emulsion 10 mg/mL 100 mL vials because of elevated endotoxin levels in certain lots.

The lot numbers being recalled are 31305429B and 31305430B.

Teva was recently notified of 41 propofol-treated human patients who experienced postoperative fever, chills and other flu-like symptoms. Testing done by the U.S. Food and Drug Administration found that the two lots used in facilities reporting febrile reactions were positive for elevated levels of endotoxin. To date, all the patients have recovered.

Although propofol is commonly used in veterinary medicine, a Teva spokeswoman said the company’s anesthetic agent is not approved for veterinary use and Teva does not market it to veterinarians.

Customers who have a tainted lot should stop using the product and return it to the distributor.

The FDA, the Centers for Disease Control and Prevention and Teva are continuing the investigation.

Teva is a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd. of Israel.

<HOME>

 

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *

___

Register

Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).
 

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.